ImmunoGen

IMGN

IMGN
ImmunoGen Stock Quote
$5.52 $0.22 4.2%
Price as of November 27, 2020, 6:00 p.m. EST View Interactive IMGN Charts

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs.

Interactive Chart


News & Analysis: ImmunoGen

The Fool has written over 200 articles on ImmunoGen.

All

Market Moves

Earnings




Why ImmunoGen Stock Jumped Today

The biotech stock bounced back quickly from Friday's sell-off, which followed the release of worse-than-expected first-quarter results.